JEMPZIM Trademark

Trademark Overview

On Friday, November 3, 2023, a trademark application was filed for JEMPZIM with the United States Patent and Trademark Office. The USPTO has given the JEMPZIM trademark a serial number of 98253780. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Tuesday, October 21, 2025. This trademark is owned by Merck Sharp & Dohme LLC. The JEMPZIM trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, anti-infectives and antivirals
jempzim

General Information

Serial Number98253780
Word MarkJEMPZIM
Filing DateFriday, November 3, 2023
Status732 - THIRD EXTENSION - GRANTED
Status DateTuesday, October 21, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 19, 2024

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, anti-infectives and antivirals

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 21, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMerck Sharp & Dohme LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressRahway, NJ 07065
Party NameMerck Sharp & Dohme LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressRahway, NJ 07065

Trademark Events

Event DateEvent Description
Tuesday, November 7, 2023NEW APPLICATION ENTERED
Tuesday, November 21, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 1, 2024ASSIGNED TO EXAMINER
Friday, February 9, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 28, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, February 28, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 19, 2024PUBLISHED FOR OPPOSITION
Tuesday, March 19, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 14, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, October 28, 2024SOU TEAS EXTENSION RECEIVED
Monday, October 28, 2024SOU EXTENSION 1 FILED
Monday, October 28, 2024SOU EXTENSION 1 GRANTED
Monday, October 28, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 14, 2025SOU TEAS EXTENSION RECEIVED
Wednesday, May 14, 2025SOU EXTENSION 2 FILED
Wednesday, May 14, 2025SOU EXTENSION 2 GRANTED
Thursday, May 15, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 14, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 14, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, October 14, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 14, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, October 21, 2025SOU TEAS EXTENSION RECEIVED
Tuesday, October 21, 2025SOU EXTENSION 3 FILED
Tuesday, October 21, 2025SOU EXTENSION 3 GRANTED
Wednesday, October 22, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

jempzim infectives antivirals anti namely preparations pharmaceutical